Efficacy and safety of add-on levetiracetam in refractory childhood epilepsy

Brain and Development

Volumn 35, Issue 5, 2013, Pages 386-391

  Kanemura, Hideaki ^a   Sano, Fumikazu ^a   Tando, Tomoko ^a   Sugita, Kanji ^a   Aihara, Masao ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Antiepileptic drugs; Children; Epilepsy with continuous spikes and waves during slow sleep (CSWS); Frontal lobe epilepsy; Levetiracetam (LEV); Refractory epilepsy

Indexed keywords

ETIRACETAM;

ADD ON THERAPY; ADOLESCENT; ADULT; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CHILD; DROWSINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FRONTAL LOBE EPILEPSY; HUMAN; INFANT; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SLOW WAVE SLEEP; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; EPILEPSY; FEMALE; HUMANS; INFANT; MALE; OUTPATIENTS; PIRACETAM; TREATMENT OUTCOME;

EID: 84875895637     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2012.07.005     Document Type: Article

References (29)

1. Yamauchi T., Kaneko S., Yagi K., Sase S. Treatment of partial seizures with gabapentin: double-blind, placebo-controlled, parallel-group study. Psychiatry Clin Neurosci 2006, 60:507-515.
2. Cereghino J.J., Biton V., Abou-Khalil B., Dreifuss F., Gauer L.J., Leppik I. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology 2000, 55:236-242.
3. Shorvon S.D., Lowenthal A., Janz D., Bielen E., Loiseau P. For the European Levetiracetam Study Group. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. Epilepsia 2000, 41:1179-1186.
4. Glauser T.A., Ayala R., Elterman R.D., Mitchell W.G., Van Orman C.B., Gauer L.J., et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in paediatric partial seizures. Neurology 2006, 66:1654-1660.
5. Aeby A., Poznanski N., Verheulpen D., Wetzburger C., Van Bogaert P. Levetiracetam efficacy in epileptic syndromes with continuous spikes and waves during slow sleep: experience in 12 cases. Epilepsia 2005, 46:1937-1942.
6. Wang S.B., Weng W.C., Fan P.C., Lee W.T. Levetiracetam in continuous spike waves during slow-wave sleep syndrome. Pediatr Neurol 2008, 39:85-90.
7. Chhun S., Troude P., Villeneuve N., Soufflet C., Napuri S., Motte J., et al. A prospective open-labeled trial with levetiracetam in pediatric epilepsy syndromes: continuous spikes and waves during sleep is definitely a target. Seizure 2011, 20:320-325.
8. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981, 22:489-501.
9. Commission on Classification and Terminology of the International League Against Epilepsy Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989, 30:389-399.
10. Mattson R.H., Cramer J.A., Collins J.F., Smith D.B., Delgado-Escueta A.V., Browne T.R., et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985, 313:145-151.
11. Perucca E. The new generation of antiepileptic drugs: advantages and disadvantages. Br J Clin Pharmacol 1996, 42:531-543.
12. Grosso S., Franzoni E., Coppola G., Iannetti P., Verrotti A., Cordelli D.M., et al. Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy. Seizure 2005, 14:248-253.
13. Lagae L., Buyse G., Ceulemans B. Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial. Seizure 2005, 14:66-71.
14. Wheless J.W., Ng Y.T. Levetiracetam in refractory pediatric epilepsy. J Child Neurol 2002, 17:413-415.
15. Kaminski R.M., Matagne A., Leclercq K., Gillard M., Michel P., Kenda B., et al. SV2A protein is a broad-spectrum anticonvulsant target: functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy. Neuropharmacology 2008, 54:715-720.
16. Gumus H., Kumandas S., Per H. Levetiracetam monotherapy in newly diagnosed cryptogenic West syndrome. Pediatr Neurol 2007, 37:350-353.
17. Capovilla G., Beccaria F., Cagdas S., Montagnini A., Segala R., Paganelli D. Efficacy of levetiracetam in pharmacoresistant continuous spikes and waves during slow sleep. Acta Neurol Scand 2004, 110:144-147.
18. Kanemura H., Aihara M. Sequential prefrontal lobe volume changes in epileptic patients with continuous spikes and waves during slow sleep. Epilepsy in children - clinical and social aspects 2011, 13-24. INTECH, Rijeka. Z.P. Gadze (Ed.).
19. Kanemura H., Sano F., Tando T., Sugita K., Aihara M. Repeated seizures induce prefrontal growth disturbance in frontal lobe epilepsy. Brain Dev 2012, 34:175-180.
20. Kanemura H., Aihara M. Growth disturbance of frontal lobe in BCECTS with frontal dysfunction. Brain Dev 2009, 31:771-774.
21. Kanemura H., Hata S., Aoyagi K., Sugita K., Aihara M. Serial changes of prefrontal lobe growth in the patients with benign childhood epilepsy with centrotemporal spikes presenting with cognitive impairments/behavioral problems. Brain Dev 2011, 33:106-113.
22. Coppola G., Franzoni E., Verrotti A., Garone C., Sarajlija J., Operto F.F., et al. Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial. Brain Dev 2007, 29:281-284.
23. Boon P., Chauvel P., Pohlmann-Eden B., Otoul C., Wroe S. Dose-response effect of levetiracetam 1000 and 2000mg/day in partial epilepsy. Epilepsy Res 2002, 48:77-89.
24. Ben-Menachem E., Falter U. For the European Levetiracetam Study Group. Efficacy and tolerability of levetiracetam 3000mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. Epilepsia 2000, 41:1276-1283.
25. Callenbach P.M.C., Arts W.F.M., Ten Houten R., Augustijn P., Gunning W.B., Peeters E.A.J., et al. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study. Eur J Paediatr Neurol 2008, 12:321-327.
26. Mohanraj R., Parker P.G., Stephen L.J., Brodie M.J. Levetiracetam in refractory epilepsy: a prospective observational study. Seizure 2005, 14:23-27.
27. Perry M.S., Benatar M. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review. Epilepsia 2007, 48:1123-1127.
28. Khurana D.S., Kothare S.V., Valencia I., Melvin J.J., Legido A. Levetiracetam monotherapy in children with epilepsy. Pediatr Neurol 2007, 36:227-230.
29. Glauser T.A. Effects of antiepileptic medications on psychiatric and behavioral comorbidities in children and adolescents with epilepsy. Epilepsy Behav 2004, 5(Suppl. 3):S25-32. [Abstract].